Skip to main content
 

Cytokine Interest Group

The Cytokine Interest Group brings together NIH and FDA scientists from many different areas working with cytokines as mediators of immune processes. It provides a platform for establishing networks for the exchange of ideas and reagents. Its activities comprise:

  1. Minisymposia: The group sponsors day-long minisymposia 3-4 times every year on cutting edge topics in cytokine research. These meetings include one or two invited talks, but primarily showcase intramural cytokine research and provide a platform for postdoctoral fellows to present their work alongside senior investigators. These meetings facilitate collaboration between groups. Recent symposia titles have included: “Cytokines in human disease pathogenesis and therapeutics”, “IL-17 and IL-23 in autoimmunity, “IL-15: Basic Research and Clinical Applications” “The IL-10 family of cytokines”, “Alternative macrophage activation in health and disease”, and Cytokines in Neuroimmunology”. The minisymposia are organized by a team of 2-3 NIH/FDA scientists.
  2. Best Paper in Cytokine Research award: The CIG also sponsors a yearly award for the “Best cytokine-related research publication” for postdoctoral fellows working at the NIH and FDA. Work must have been performed while the Fellow is/was at the NIH/FDA. The papers are ranked by the members of the CIG steering committee. The winning authors are presented with a plaque during our spring symposium and, if still at the NIH/FDA, a travel award to help them attend a scientific conference. There is great interest in this highly competitive award among the postdoctoral fellow community. The CIG steering committee is formed by NIH/FDA scientists at different career stages and meets quarterly.

Mailing List

To join the Cytokine Interest Group mailing list, please visit the Cytokine Interest Group Listserv home page, then click the “Subscribe or Unsubscribe” link in the right sidebar.

Chairs

Advisors


The page was last updated on Monday, September 11, 2017 - 9:08am